Table: begin end state 1 5 non-cytoplasmic 6 24 transmembrane 25 30 cytoplasmic 31 52 transmembrane 53 53 non-cytoplasmic 54 55 transmembrane 56 60 non-cytoplasmic 61 82 transmembrane 83 102 cytoplasmic 103 123 transmembrane 124 128 non-cytoplasmic 129 151 transmembrane 152 157 cytoplasmic 158 179 transmembrane 180 199 non-cytoplasmic 200 223 transmembrane 224 234 cytoplasmic 235 257 transmembrane 258 262 non-cytoplasmic 263 281 transmembrane 282 321 cytoplasmic 322 340 transmembrane 341 368 non-cytoplasmic 369 391 transmembrane 392 403 cytoplasmic 404 423 transmembrane 424 447 non-cytoplasmic 448 467 transmembrane 468 478 cytoplasmic 479 500 transmembrane 501 505 non-cytoplasmic 506 525 transmembrane 526 536 cytoplasmic 537 556 transmembrane 557 564 non-cytoplasmic
Input: >WP_011914396.1 NCBI__GCF_000013785.1:WP_011914396.1 MSNGLLALFAFTPILLAAVMLIGLRWPASRAMPLVYLFTAAIGLFVWDMSFNRIIASTLQ GLVITLGLLWIIFGAILLLNTLKHSGGITAIRAGFTTISPDRRIQAIIIAWLFGCFIEGA SGFGTPAAIAAPLLVAVGFPAMAAVLLGMLVQSTPVSFGAVGTPIVVGINSGLDTATIGA QLTAQGSSWSIFLQQITSSVAITHAIVGTVMPLVMVLMLTRFFGKEKSWKAGFEVLPFAI FAGLAFTLPYAATGIFLGPEFPSLLGGLVGLAIVTTAARFKFLTPKTTWDFADAKEWPAE WLGTIEMKLDDIAARPMSAFRAWLPYVLVGALLVISRVFPQVGAALKSVSVAFANILGEA GINAGIEPLYLPGGILVAVVLITFFLHGMRAAELKAAVKESSSVLLSAGFVLLFTVPMVR ILINSGVNGAELASMPIVMARYVADSVGGIYPLLAPSVGALGAFLAGSNTVSNMMFSQFQ FGVAQSLGISGAMVVATQAVGAAAGNMVAIHNVVAASATVGLLGREGSTLRKTVWPTLYY VLFTGAIGLIAIYVLGVTDPLVGV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server